Nucleic acid aptamers as antithrombotic agents: Opportunities in extracellular therapeutics
Thomas J. Povsic, Richard Becker(Clinical Research Institute), Mauricio G. Cohen(Santa Ana College), Bruce A. Sullenger(Duke University), Christopher Rusconi(Electronic BioSciences (United States))
Cited by 48
Related Papers
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k
Notch Promotes Radioresistance of Glioma Stem Cells
|Stem Cells|2009|643
Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation
|Journal of the American College of Cardiology|2013|643